Alzheimer's Disease & Dementia

• 

  Alzheimer's Disease & Dementia

  Advances in Blood-based Biomarkers for Alzheimer’s Disease
• 

  Alzheimer's Disease & Dementia

  Molecular Pathogenesis of Alzheimer’s Disease

  Sophia Schedin Weiss , Lars Tjernberg

  US Neurology. 2019;15(1):14–6.
• 

  Alzheimer's Disease & Dementia

  Latest Developments in Preclinical Alzheimer’s Disease

  Martin R Farlow

  US Neurology. 2019;15(1):12–3
• 

  Alzheimer's Disease & Dementia

  Latest Developments in Preclinical Alzheimer’s Disease

  US Neurology. 2019;15(1):12–3
• 

  Alzheimer's Disease & Dementia

  DLB Expert Interview: Guillermo Garcia-Ribas, Richard Dodel, Evelien Lemstra, Alessandro Padovani
• 

  Alzheimer's Disease & Dementia

  Zuzana Walker – Diagnosis of DLB (Part 1 and 2)
• 

  Alzheimer's Disease & Dementia

  Ian McKeith – DLB meeting, London 2018
• 

  Alzheimer's Disease & Dementia

  AAIC 2019: Abstract submission
• 

  Alzheimer's Disease & Dementia

  George Perry – Therapeutic targets in Alzheimer’s disease
• 

  Alzheimer's Disease & Dementia

  Philip Scheltens, EAN 2018 – Evolution of Alzheimer’s disease and dementia
• 

  Alzheimer's Disease & Dementia

  Jeffrey L Cummings – Monoclonal antibodies in the treatment of Alzheimer’s disease
• 

  Alzheimer's Disease & Dementia

  Impact of Improving Wellbeing and Health in Dementia (WHELD) trial
• 

  Alzheimer's Disease & Dementia

  EAN 2017 – Sean Knox EPAD Interview
• 

  Alzheimer's Disease & Dementia

  AAN 2017 – Martin Farlow Interview – Part 2
• 

  Alzheimer's Disease & Dementia

  AAN 2017 – Martin Farlow Interview – Part 1
• 

  Alzheimer's Disease & Dementia

  AAN 2017 – Jeff Cummings Interview
• 

  Alzheimer's Disease & Dementia

  Amyloid Beta & Alzheimer’s Disease Video – Brigham and Women’s Hospital
• 

  Alzheimer's Disease & Dementia

  TDP43 and Alzheimer’s Study